| Analysis | Samples | Factors | Units |
|---|---|---|---|
| GC POSITIVE ION MODE | Control_ 1 | Treatment:Control | mM |
| GC POSITIVE ION MODE | Control_ 2 | Treatment:Control | mM |
| GC POSITIVE ION MODE | Control_ 3 | Treatment:Control | mM |
| GC POSITIVE ION MODE | Control_ 4 | Treatment:Control | mM |
| GC POSITIVE ION MODE | Control_ 5 | Treatment:Control | mM |
| GC POSITIVE ION MODE | Fer1-1 | Treatment:Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | Fer1-2 | Treatment:Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | Fer1-3 | Treatment:Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | Fer1-4 | Treatment:Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | Fer1-5 | Treatment:Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | Fer1-6 | Treatment:Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | RSL3_1 | Treatment:RSL3 | mM |
| GC POSITIVE ION MODE | RSL3_2 | Treatment:RSL3 | mM |
| GC POSITIVE ION MODE | RSL3_3 | Treatment:RSL3 | mM |
| GC POSITIVE ION MODE | RSL3_4 | Treatment:RSL3 | mM |
| GC POSITIVE ION MODE | RSL3_5 | Treatment:RSL3 | mM |
| GC POSITIVE ION MODE | RSL3_6 | Treatment:RSL3 | mM |
| GC POSITIVE ION MODE | RF_1 | Treatment:RSL3 + Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | RF_2 | Treatment:RSL3 + Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | RF_3 | Treatment:RSL3 + Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | RF_4 | Treatment:RSL3 + Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | RF_5 | Treatment:RSL3 + Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | RF_6 | Treatment:RSL3 + Ferrostatin-1 | mM |
| GC POSITIVE ION MODE | RT_1 | Treatment:RSL3 + TSM-1005-44 | mM |
| GC POSITIVE ION MODE | RT_2 | Treatment:RSL3 + TSM-1005-44 | mM |
| GC POSITIVE ION MODE | RT_3 | Treatment:RSL3 + TSM-1005-44 | mM |
| GC POSITIVE ION MODE | RT_4 | Treatment:RSL3 + TSM-1005-44 | mM |
| GC POSITIVE ION MODE | RT_5 | Treatment:RSL3 + TSM-1005-44 | mM |
| GC POSITIVE ION MODE | RX_1 | Treatment:RSL3 + XJB-5-131 | mM |
| GC POSITIVE ION MODE | RX_2 | Treatment:RSL3 + XJB-5-131 | mM |
| GC POSITIVE ION MODE | RX_3 | Treatment:RSL3 + XJB-5-131 | mM |
| GC POSITIVE ION MODE | RX_4 | Treatment:RSL3 + XJB-5-131 | mM |
| GC POSITIVE ION MODE | RX_5 | Treatment:RSL3 + XJB-5-131 | mM |
| GC POSITIVE ION MODE | RX_6 | Treatment:RSL3 + XJB-5-131 | mM |
| GC POSITIVE ION MODE | TSM_1 | Treatment:TSM-1005-44 | mM |
| GC POSITIVE ION MODE | TSM_3 | Treatment:TSM-1005-44 | mM |
| GC POSITIVE ION MODE | TSM_4 | Treatment:TSM-1005-44 | mM |
| GC POSITIVE ION MODE | TSM_5 | Treatment:TSM-1005-44 | mM |
| GC POSITIVE ION MODE | TSM_6 | Treatment:TSM-1005-44 | mM |
| GC POSITIVE ION MODE | XJB_1 | Treatment:XJB-5-131 | mM |
| GC POSITIVE ION MODE | XJB_2 | Treatment:XJB-5-131 | mM |
| GC POSITIVE ION MODE | XJB_3 | Treatment:XJB-5-131 | mM |
| GC POSITIVE ION MODE | XJB_4 | Treatment:XJB-5-131 | mM |
| GC POSITIVE ION MODE | XJB_5 | Treatment:XJB-5-131 | mM |
Return to study ST002080 main page
Download data matrix(Effects of Ferroptosis on the Metabolome in Cardiac Cells: The Role of Glutaminolysis GC POSITIVE ION MODE)
- Metabolomics Workbench
|